/Companies

CardioKinetix

Defunct

Menlo Park, US · 5 known investors

Find your way into CardioKinetix

CardioKinetix developed the Parachute Ventricular Partitioning Device, a catheter-based implant that partitions the left ventricle to help restore cardiac function after heart attacks.

Founders & leadership

BH
Brett HaleExecutive
MSMaria Sainz
Maria SainzExecutive

Board

LB
Lou BockBoard director
JD
Jeani DelagardelleBoard directorVenture Partner at New Leaf Venture Partners
CT
Casey TanseyBoard director
RF
Rodney FergusonBoard director
PL
Paul LaVioletteBoard director
FG
Frank GentileBoard director
EF
Eric FainBoard director

Investors · 5

Reported raises · per SEC filings

Form D private placements

$30.7M disclosed across 1 round · 2014

▶$30.7MraisedDec 2014 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lou BockDirector
  • Brett HaleExecutive Officer
  • Jeani DelagardelleDirector
  • Casey TanseyDirector
  • Frank GentileDirector
  • Maria SainzExecutive Officer, Director
  • Eric FainDirector
  • Rodney FergusonDirector
  • Paul LaVioletteDirector
Offering amount
$37.7M
Amount sold
$30.7M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does CardioKinetix do?
CardioKinetix developed the Parachute Ventricular Partitioning Device, a catheter-based implant that partitions the left ventricle to help restore cardiac function after heart attacks.
Who are CardioKinetix's investors?
CardioKinetix's investors include Archer Capital Group, Archer Venture Capital, SV Health Investors, New Leaf Venture Partners, SV Life Sciences.
How much funding has CardioKinetix raised?
CardioKinetix has disclosed $30.7M raised across 1 round.
Where is CardioKinetix headquartered?
CardioKinetix is headquartered in Menlo Park, US.